Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 42.95
+1.20 (2.87%)
Jul 29, 2026, 3:39 PM CET
Dermapharm Holding SE Market Cap
Dermapharm Holding SE has a market cap or net worth of €2.07 billion as of July 29, 2026. Its market cap has increased by 9.60% in one year.
Market Cap
2.07B
Enterprise Value
2.88B
Revenue
1.18B
Ranking
n/a
PE Ratio
15.58
Stock Price
€42.95
ChartMarket Cap Chart
Since February 9, 2018, Dermapharm Holding SE's market cap has increased from 1.40B to 2.07B, an increase of 47.75%. That is a compound annual growth rate of 4.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 2.07B | -2.37% |
| Dec 30, 2025 | 2.12B | 1.16% |
| Dec 30, 2024 | 2.09B | -8.12% |
| Dec 29, 2023 | 2.28B | 12.85% |
| Dec 30, 2022 | 2.02B | -57.98% |
| Dec 30, 2021 | 4.81B | 56.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 61.63B |
| Bayer Aktiengesellschaft | 46.40B |
| Siemens Healthineers AG | 39.58B |
| Fresenius SE & Co. KGaA | 24.92B |
| Ottobock SE & Co. KGaA | 3.58B |
| Fielmann Group AG | 3.48B |
| SCHOTT Pharma AG & Co. KGaA | 3.25B |
| Carl Zeiss Meditec AG | 2.52B |